Compounds > 1h-imidazo(4,5-b)pyridine
Page last updated: 2024-08-24

1h-imidazo(4,5-b)pyridine and Leishmaniasis, Visceral

1h-imidazo(4,5-b)pyridine has been researched along with Leishmaniasis, Visceral in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Caljon, G; Carlson, JE; da Silva Emery, F; Dichiara, M; Ferrins, L; Huang, AX; Jalani, HB; Klug, DM; Matheeussen, A; Millard, CC; Perry, B; Pollastri, MP; Quotadamo, A; Silva, DG; Simpson, QJ; Sjö, P; Todd, MH; Tse, EG; Vleminckx, M; Zheng, SL1

Other Studies

1 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Leishmaniasis, Visceral

ArticleYear
Structure-Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis.
    ACS infectious diseases, 2023, 08-11, Volume: 9, Issue:8

    Topics: Humans; Imidazoles; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Neglected Diseases

2023